首页> 外文期刊>Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research >Potassium Bicarbonate Supplementation Lowers Bone Turnover and Calcium Excretion in Older Men and Women: A Randomized Dose-Finding Trial
【24h】

Potassium Bicarbonate Supplementation Lowers Bone Turnover and Calcium Excretion in Older Men and Women: A Randomized Dose-Finding Trial

机译:碳酸氢钾补充剂可降低老年男性和女性的骨质流失和钙排泄:一项随机的剂量发现试验

获取原文
获取原文并翻译 | 示例
           

摘要

The acid load accompanying modern diets may have adverse effects on bone and muscle metabolism. Treatment with alkaline salts of potassium can neutralize the acid load, but the optimal amount of alkali is not established. Our objective was to determine the effectiveness of two doses of potassium bicarbonate (KHCO3) compared with placebo on biochemical markers of bone turnover, and calcium and nitrogen (N) excretion. In this double-blind, randomized, placebo-controlled study, 244 men and women age 50 years and older were randomized to placebo or 1mmol/kg or 1.5mmol/kg of KHCO3 daily for 3 months; 233 completed the study. The primary outcomes were changes in 24-hour urinary N-telopeptide (NTX) and N; changes in these measures were compared across the treatment groups. Exploratory outcomes included 24-hour urinary calcium excretion, serum amino-terminal propeptide of type I procollagen (P1NP), and muscle strength and function assessments. The median administered doses in the low-dose and high-dose groups were 81 mmol/day and 122 mmol/day, respectively. When compared with placebo, urinary NTX declined significantly in the low-dose group (p=0.012, after adjustment for baseline NTX, gender, and change in urine creatinine) and serum P1NP declined significantly in the low-dose group (p=0.004, adjusted for baseline P1NP and gender). Urinary calcium declined significantly in both KHCO3 groups versus placebo (p < 0.001, adjusted for baseline urinary calcium, gender, and changes in urine creatinine and calcium intake). There was no significant effect of either dose of KHCO3 on urinary N excretion or on the physical strength and function measures. KHCO3 has favorable effects on bone turnover and calcium excretion and the lower dose appears to be the more effective dose. Long-term trials to assess the effect of alkali on bone mass and fracture risk are needed. (c) 2015 American Society for Bone and Mineral Research.
机译:现代饮食所伴随的酸负荷可能对骨骼和肌肉的新陈代谢产生不利影响。用钾的碱金属盐处理可以中和酸负荷,但是碱的最佳量尚未建立。我们的目标是确定与安慰剂相比,两剂碳酸氢钾(KHCO3)在骨转换和钙和氮(N)排泄的生化指标上的有效性。在这项双盲,随机,安慰剂对照研究中,将244名年龄在50岁及以上的男女随机分配到安慰剂或1mmol / kg或1.5mmol / kg的KHCO3中,持续3个月; 233完成了研究。主要结局是24小时尿N-端肽(NTX)和N的变化。在各治疗组之间比较了这些措施的变化。探索性结果包括24小时尿钙排泄,I型胶原蛋白(P1NP)的血清氨基末端前肽以及肌肉力量和功能评估。低剂量和高剂量组的中位给药剂量分别为81 mmol /天和122 mmol /天。与安慰剂相比,低剂量组尿NTX显着下降(p = 0.012,校正基线NTX,性别和尿肌酐变化后),低剂量组血清P1NP显着下降(p = 0.004,根据基线P1NP和性别进行调整)。与安慰剂相比,两个KHCO3组的尿钙均显着下降(p <0.001,已根据基线尿钙,性别,尿肌酐和钙摄入量的变化进行了调整)。剂量的KHCO3对尿N排泄或对身体强度和功能指标均无显着影响。 KHCO3对骨转换和钙排泄有有利影响,剂量越低似乎越有效。需要进行长期试验以评估碱对骨量和骨折风险的影响。 (c)2015年美国骨与矿物质研究学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号